Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): protocol for identification of novel biomarkers via neurophysiology.
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): protocol for identification of novel biomarkers via neurophysiology.
复制标题
磁休克疗法治疗抑郁症的疗效与安全性确证性试验(CREST - MST):通过神经生理学鉴定新型生物标志物的方案
DOI:
10.1186/s13063-021-05873-7
复制
发表时间:
2021-12-11
期刊:
影响因子:
2.5
通讯作者:
Blumberger DM
中科院分区:
文献类型:
--
作者:
Daskalakis ZJ;McClintock SM;Hadas I;Kallioniemi E;Zomorrodi R;Throop A;Palmer L;Farzan F;Thorpe KE;Tamminga C;Blumberger DM
Electroconvulsive therapy (ECT) is the most effective treatment for treatment-resistant depression (TRD), especially for acute suicidal ideation, but the associated cognitive adverse effects and negative stigma limit its use. Another seizure therapy under development is magnetic seizure therapy (MST), which could potentially overcome the restrictions associated with ECT with similar efficacy. The neurophysiological targets and mechanisms of seizure therapy, however, remain poorly understood. This neurophysiological study protocol is published as a companion to the overall Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST) protocol that describes our two-site, double-blind, randomized, non-inferiority clinical trial to develop MST as an effective and safe treatment for TRD. Our aim for the neurophysiological component of the study is to evaluate two biomarkers, one to predict remission of suicidal ideation (primary outcome) and the other to predict cognitive impairment (secondary outcome). Suicidal ideation will be assessed through cortical inhibition, which according to our preliminary studies, correlates with remission of suicidal ideation. Cortical inhibition will be measured with simultaneous transcranial magnetic stimulation (TMS) and electroencephalography (EEG), TMS-EEG, which measures TMS-evoked EEG activity. Cognitive adverse effects associated with seizure therapy, on the contrary, will be evaluated via multiscale entropy analysis reflecting the complexity of ongoing resting-state EEG activity. ECT and MST are known to influence cortical inhibition associated with depression, suicidal ideation severity, and clinical outcome. Therefore, evaluating cortical inhibition and brain temporal dynamics will help understand the pathophysiology of depression and suicidal ideation and define new biological targets that could aid clinicians in diagnosing and selecting treatments. Resting-state EEG complexity was previously associated with the degree of cognitive side effects after a seizure therapy. This neurophysiological metric may help clinicians assess the risk for adverse effects caused by these useful and effective treatments. ClinicalTrials.govNCT03191058. Registered on June 19, 2017.
登录
查看更多内容
影响因子:
2.5
作者:
Daskalakis ZJ;Tamminga C;Throop A;Palmer L;Dimitrova J;Farzan F;Thorpe KE;McClintock SM;Blumberger DM
通讯作者:
Blumberger DM
影响因子:
6.8
作者:
Hadas I;Zomorrodi R;Hill AT;Sun Y;Fitzgerald PB;Blumberger DM;Daskalakis ZJ
通讯作者:
Daskalakis ZJ
影响因子:
14.5
作者:
Farzan, Faranak;Atluri, Sravya;Daskalakis, Zafiris J.
通讯作者:
Daskalakis, Zafiris J.
影响因子:
7.7
作者:
Sackeim, Harold A.;Prudic, Joan;Devanand, D. P.
通讯作者:
Devanand, D. P.
影响因子:
4.8
作者:
Kayser, Sarah;Bewernick, Bettina H.;Schlaepfer, Thomas E.
通讯作者:
Schlaepfer, Thomas E.